Protocol on a multicentre statistical and economic modelling study of risk-based stratified and personalised screening for diabetes and its complications in India (SMART India).


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
12 12 2020
Historique:
entrez: 14 12 2020
pubmed: 15 12 2020
medline: 20 5 2021
Statut: epublish

Résumé

The aim of this study is to develop practical and affordable models to (a) diagnose people with diabetes and prediabetes and (b) identify those at risk of diabetes complications so that these models can be applied to the population in low-income and middle-income countries (LMIC) where laboratory tests are unaffordable. This statistical and economic modelling study will be done on at least 48 000 prospectively recruited participants aged 40 years or above through community screening across 20 predefined regions in India. Each participant will be tested for capillary random blood glucose (RBG) and complete a detailed health-related questionnaire. People with known diabetes and all participants with predefined levels of RBG will undergo further tests, including point-of-care (POC) glycated haemoglobin (HbA1c), POC lipid profile and POC urine test for microalbuminuria, retinal photography using non-mydriatic hand-held retinal camera, visual acuity assessment in both eyes and complete quality of life questionnaires. The primary aim of the study is to develop a model and assess its diagnostic performance to predict HbA1c diagnosed diabetes from simple tests that can be applied in resource-limited settings; secondary outcomes include RBG cut-off for definition of prediabetes, diagnostic accuracy of cost-effective risk stratification models for diabetic retinopathy and models for identifying those at risk of complications of diabetes. Diagnostic accuracy inter-tests agreement, statistical and economic modelling will be performed, accounting for clustering effects. The Indian Council of Medical Research/Health Ministry Screening Committee (HMSC/2018-0494 dated 17 December 2018 and institutional ethics committees of all the participating institutions approved the study. Results will be published in peer-reviewed journals and will be presented at national and international conferences. ISRCTN57962668 V1.0 24/09/2018.

Identifiants

pubmed: 33310798
pii: bmjopen-2020-039657
doi: 10.1136/bmjopen-2020-039657
pmc: PMC7735124
doi:

Substances chimiques

Glycated Hemoglobin A 0

Banques de données

ISRCTN
['ISRCTN57962668']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e039657

Subventions

Organisme : Medical Research Council
ID : MR/P027881/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Diabetes. 2011 Sep;3(3):232-7
pubmed: 21631894
Ophthalmology. 2003 Sep;110(9):1677-82
pubmed: 13129861
Diabetes Care. 2001 Nov;24(11):1899-903
pubmed: 11679454
Ann Pharmacother. 2005 Jun;39(6):1024-8
pubmed: 15840733
Rev Endocr Metab Disord. 2020 Dec;21(4):613-629
pubmed: 32128655
Ophthalmic Epidemiol. 2008 Jul-Aug;15(4):218-23
pubmed: 18780254
Clin Diabetes Endocrinol. 2019 May 9;5:5
pubmed: 31086677
Indian J Endocrinol Metab. 2013 Jan;17(1):31-6
pubmed: 23776850
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
BMJ. 2009 Mar 31;338:b604
pubmed: 19336487
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4007-15
pubmed: 16249474
J Pak Med Assoc. 2017 Sep;67(9):1353-1356
pubmed: 28924273
Qual Life Res. 2008 Apr;17(3):463-73
pubmed: 18320352
Trop Med Int Health. 2014 Dec;19(12):1515-9
pubmed: 25294180
Prev Med Rep. 2017 Apr 04;6:322-328
pubmed: 28451518
Heart. 2018 Apr;104(7):581-587
pubmed: 29066611
East Afr Med J. 2002 Sep;79(9):491-5
pubmed: 12625691
PLoS One. 2015 Sep 24;10(9):e0138285
pubmed: 26401839
Diabet Med. 1994 Aug-Sep;11(7):705-8
pubmed: 7955999
J Diabetes Clin Res. 2019;1(2):53-58
pubmed: 32133459
QJM. 2011 Mar;104(3):231-6
pubmed: 20934980
J Gen Intern Med. 2008 May;23(5):528-35
pubmed: 18335280
BMJ. 2009 May 28;338:b605
pubmed: 19477892
JAMA Ophthalmol. 2019 Aug 8;:
pubmed: 31393538
Ophthalmology. 2013 Mar;120(3):566-573
pubmed: 23211635
BMJ. 2017 Jan 4;356:i6538
pubmed: 28052845
Diabetes Care. 2009 Apr;32(4):641-3
pubmed: 19073758
Health Technol Assess. 2015 Sep;19(74):1-116
pubmed: 26384314

Auteurs

Sobha Sivaprasad (S)

NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK s.sivaprasad@ucl.ac.uk.
Vision Sciences, UCL Institute of Ophthalmology, London, UK.

Rajiv Raman (R)

Retina Department, Vision Research Foundation, Sankara Nethralaya, Chennai, India.

Ramachandran Rajalakshmi (R)

Deaprtment of Diabetes, Madras Diabetes Research Foundation, Dr Mohan's Diabetes Specialities Centre, Chennai, India.

Viswanathan Mohan (V)

Deaprtment of Diabetes, Madras Diabetes Research Foundation, Dr Mohan's Diabetes Specialities Centre, Chennai, India.

Mohan Deepa (M)

Deaprtment of Diabetes, Madras Diabetes Research Foundation, Dr Mohan's Diabetes Specialities Centre, Chennai, India.

Taraprasad Das (T)

Retina Department, Hyderabad Eye Research Foundation, LV Prasad Eye Institute, Hyderabad, India.

Kim Ramasamy (K)

Retina Department, Aravind Medical Research Foundation, Madurai, India.

A Toby Prevost (AT)

Nightingale-Saunders Clinical Trials and Epidemiology Unit, King's College London, London, UK.

Raphael Wittenberg (R)

Centre for Health Service Economics and Organisation, University of Oxford, Oxford, UK.

Gopalakrishnan Netuveli (G)

Institute for Connected Communities, University of East London, London, UK.

Gopal Lingam (G)

Department of Ophthalmology, National University Hospital, Singapore.

Wasim Hanif (W)

Department of Diabetes, University Hospital, Birmingham, UK.

Radha Ramakrishnan (R)

Vision Sciences, UCL Institute of Ophthalmology, London, UK.

Jayashree Ramu (J)

NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK.

Janani Surya (J)

Retina Department, Vision Research Foundation, Sankara Nethralaya, Chennai, India.

Dolores Conroy (D)

Vision Sciences, UCL Institute of Ophthalmology, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH